NEW YORK, April 18 - In a sign that RNAi is truly creating a buzz in the life sciences community, Ribozyme Pharmaceuticals announced Wednesday that it was changing its name to Sirna Therapeutics, and changing its stock symbol to RNAI.
...and receive Daily News bulletins.
Already have an account?Login Now.
The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.
Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.
In Science this week: in vitro generation of human reproductive cells, and more.
Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.